title: Conservative management of medication-related osteonecrosis of the maxilla with an obturator prosthesis.
abstract: Advanced maxillary medication-related osteonecrosis of the jaw can cause extensive hard and soft tissue destruction that results in long-term oroantral fistulae. The surgical treatment of medication-related osteonecrosis of the jaw may relieve acute symptoms and eliminate the signs of inflammation, but the primary and sustained plastic closure of these defects can challenge both the clinician and the patients. Although the use of obturator prostheses for maxillary defects after ablative oncologic surgery is well documented, studies about this treatment for similar medication-related osteonecrosis of the jaw-related defects are missing. This presentation of clinical situations describes the use of obturators as a conservative alternative to repetitive surgery for the rehabilitation of selected maxillary defects with oroantral communications.
authors.affiliation: Resident, Department of Oral and Maxillofacial Surgery, University of Munich, Munich, Germany. Electronic address: matthias_troeltzsch@hotmail.com.
authors.forename: Matthias
authors.initials: M
authors.lastname: Troeltzsch
authors.affiliation: Resident, Department of Oral and Maxillofacial Surgery, University of Munich, Munich, Germany.
authors.forename: Florian
authors.initials: F
authors.lastname: Probst
authors.affiliation: Resident, Department of Oral and Maxillofacial Surgery, University of Göttingen, Göttingen, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Troeltzsch
authors.affiliation: Professor and Department Chair, Department of Oral and Maxillofacial Surgery, University of Munich, Munich, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Ehrenfeld
authors.affiliation: Associate Professor, Department of Oral and Maxillofacial Surgery, University of Munich, Munich, Germany.
authors.forename: Sven
authors.initials: S
authors.lastname: Otto
mesh_terms: D000273:Adipose Tissue / Q000637:transplantation; D000368:Aged; D000369:Aged, 80 and over; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000601:surgery / Q000628:therapy*; D050071:Bone Density Conservation Agents / Q000009:adverse effects; D003646:Debridement / Q000379:methods; D003819:Denture Bases; D003779:Denture Design; D003832:Denture, Partial, Removable; D004164:Diphosphonates / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects; D008297:Male; D008439:Maxillary Diseases / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D009957:Oroantral Fistula / Q000209:etiology / Q000628:therapy*; D010158:Palatal Obturators; D013529:Surgical Wound Dehiscence / Q000209:etiology / Q000628:therapy; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid